ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Pfizer steps up academic partnering

by Rick Mullin
January 15, 2018 | APPEARED IN VOLUME 96, ISSUE 3

Pfizer is launching an early-stage academic partnership program it calls Innovative Target Exploration Network, focused on building relationships with academic researchers before identifying preclinical candidates. Pfizer named the University of Cambridge, University of Oxford, and University of Texas Southwestern Medical Center as its initial partners under the program. ITEN is a follow-up to Pfizer’s Centers for Therapeutic Innovation, an academic and institutional research collaboration model that picked up later-stage development candidates.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment